Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Other Non-Current Assets: 2020-2024

Historic Other Non-Current Assets for Agilon Health (AGL) over the last 5 years, with FY2024 value amounting to $151.1 million.

  • Agilon Health's Other Non-Current Assets fell 1379.42% to $132.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $132.7 million, marking a year-over-year decrease of 1379.42%. This contributed to the annual value of $151.1 million for FY2024, which is 400.79% up from last year.
  • As of FY2024, Agilon Health's Other Non-Current Assets stood at $151.1 million, which was up 400.79% from $145.3 million recorded in FY2023.
  • Agilon Health's 5-year Other Non-Current Assets high stood at $151.1 million for FY2024, and its period low was $43.7 million during FY2020.
  • In the last 5 years, Agilon Health's Other Non-Current Assets had a median value of $113.0 million in 2021 and averaged $111.8 million.
  • As far as peak fluctuations go, Agilon Health's Other Non-Current Assets soared by 15848.51% in 2021, and later plummeted by 628.29% in 2022.
  • Over the past 5 years, Agilon Health's Other Non-Current Assets (Annual) stood at $43.7 million in 2020, then surged by 158.49% to $113.0 million in 2021, then fell by 6.28% to $105.9 million in 2022, then surged by 37.27% to $145.3 million in 2023, then grew by 4.01% to $151.1 million in 2024.
  • Its last three reported values are $151.1 million in FY2024, $145.3 million for FY2023, and $105.9 million during FY2022.